Intra-Cellular Therapies Company

Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.

Funding Status: IPO
Headquarters: New York, New York, United States
Founded Date: 2002
Technology: Small Molecules
Employee Number: 51-100
Estimated Revenue: $1M to $10M
Industry: PharmTech